Publications by authors named "Diane Joseph"

Claim this Profile
J
Japan-United States of America Harmonized Assessment by Randomized Multicentre Study of OrbusNEich's Combo StEnt (Japan-USA HARMONEE) study: primary results of the pivotal registration study of combined endothelial progenitor cell capture and drug-eluting stent in patients with ischaemic coronary disease and non-ST-elevation acute coronary syndrome.
Shigeru Saito, Mitchell W Krucoff, Shigeru Nakamura, Roxana Mehran, Akiko Maehara, Diane Joseph

Eur Heart J· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized, double-blind, placebo-controlled trial to evaluate the safety and effectiveness of intracoronary application of a novel bioabsorbable cardiac matrix for the prevention of ventricular remodeling after large ST-segment elevation myocardial infarction: Rationale and design of the PRESERVATION I trial.
Sunil V Rao, Uwe Zeymer, Pamela S Douglas, Hussein Al-Khalidi, Jingyu Liu, Diane S Joseph

Am Heart J· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genome-wide association study of perioperative myocardial infarction after coronary artery bypass surgery.
Miklos D Kertai, Yi-Ju Li, Yen-Wei Li, Yunqi Ji, John Alexander, Diane Joseph, Joseph P Mathew

BMJ Open· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A double-blind, randomized, controlled, multicenter study to assess the safety and cardiovascular effects of skeletal myoblast implantation by catheter delivery in patients with chronic heart failure after myocardial infarction.
Thomas J Povsic, Christopher M O'Connor, Timothy Henry, Andrew Taussig, Dean J Kereiakes, Diane Joseph

Am Heart J· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized, partially blinded, multicenter, active-controlled, dose-ranging study assessing the safety, efficacy, and pharmacodynamics of the REG1 anticoagulation system in patients with acute coronary syndromes: design and rationale of the RADAR Phase IIb trial.
Thomas J Povsic, Mauricio G Cohen, Roxana Mehran, Christopher E Buller, Christoph Bode, Diane Joseph

Am Heart J· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and tolerability of SCH 530348 in patients undergoing non-urgent percutaneous coronary intervention: a randomised, double-blind, placebo-controlled phase II study.
Richard C Becker, David J Moliterno, Lisa K Jennings, Karen S Pieper, Jinglan Pei, Diane Joseph

Lancet· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A helpline for patients with chronic dermatological conditions.
Diane Joseph, Jane Day

Br J Nurs· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The PRoject of Ex-vivo Vein graft ENgineering via Transfection IV (PREVENT IV) trial: study rationale, design, and baseline patient characteristics.
John H Alexander, T Bruce Ferguson, Diane M Joseph, Michael J Mack, Randall K Wolf

Am Heart J· October 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimal duration of eptifibatide infusion in percutaneous coronary intervention (an ESPRIT substudy).
Abdallah G Rebeiz, Jean-Pierre Dery, Anastasios A Tsiatis, J Conor O'shea, Brent A Johnson, Diane Joseph

Am J Cardiol· October 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reduction of myocardial ischemic injury following coronary intervention (the MC-1 to Eliminate Necrosis and Damage trial).
David E Kandzari, Marino Labinaz, Warren J Cantor, Mina Madan, Dianne S Gallup, Diane Joseph

Am J Cardiol· September 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is glycoprotein IIb/IIIa antagonism as effective in women as in men following percutaneous coronary intervention?. Lessons from the ESPRIT study.
Laura S Fernandes, James E Tcheng, J Conor O'Shea, Bonnie Weiner, Todd J Lorenz, Diane Joseph

J Am Coll Cardiol· September 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis